GCP
MLNT

GSA Capital Partners’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

GSA Capital Partners’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,288
Closed -$65K – 1931
2018
Q3 		$65K Buy
+3,288
New +$65K ﹤0.01% 1581